CAH vs DXC · P/E 35, rev $254.25B vs P/E 7.6, rev $12.64B
Cardinal Health Inc (CAH) versus DXC Technology Co (DXC) — a side-by-side from cached financials, not a winner call.
Cardinal Health Inc (CAH) is a medical distribution company listed on NYSE.
DXC Technology Co (DXC) is a information technology services company listed on US.
Latest reported CAH revenue for 2026-06-30 was $254.25B. Net income was $1.71B. Revenue was up 14.2% from 2025-06-30 to 2026-06-30. CAH currently screens at market cap $53.00B and trailing P/E 34.6.
Latest reported DXC revenue for 2026-03-31 was $12.64B. Net income was $18.0M. Revenue was down 1.8% from 2025-03-31 to 2026-03-31. DXC currently screens at market cap $2.92B and trailing P/E 7.6.
CAH currently screens at market cap $53.00B and trailing P/E 34.6. DXC currently screens at market cap $2.92B and trailing P/E 7.6.
Not investment advice. Open the CAH and DXC stock pages for the full models.
Not investment advice.